Related Experiment Video
Updated: Feb 26, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Increased White Matter Inflammation in Aging- and Alzheimer's Disease Brain
Divya Raj1, Zhuoran Yin1,2, Marjolein Breur3
1Department of Neuroscience, Section Medical Physiology, University Medical Center Groningen, University of GroningenGroningen, Netherlands.
Abstract:
Chronic neuroinflammation, which is primarily mediated by microglia, plays an essential role in aging and neurodegeneration. It is still unclear whether this microglia-induced neuroinflammation occurs globally or is confined to distinct brain regions. In this study, we investigated microglia activity in various brain regions upon healthy aging and Alzheimer's disease (AD)-related pathology in both human and mouse samples. In purified microglia isolated from aging mouse brains, we found a profound gene expression pattern related to pro-inflammatory processes, phagocytosis, and lipid homeostasis. Particularly in white matter microglia of 24-month-old mice, abundant expression of phagocytic markers including Mac-2, Axl, CD16/32, Dectin1, CD11c, and CD36 was detected. Interestingly, in white matter of human brain tissue the first signs of inflammatory activity were already detected during middle age. Thus quantification of microglial proteins, such as CD68 (commonly associated with phagocytosis) and HLA-DR (associated with antigen presentation), in postmortem human white matter brain tissue showed an age-dependent increase in immunoreactivity already in middle-aged people (53.2 ± 2.0 years). This early inflammation was also detectable by non-invasive positron emission tomography imaging using [11C]-(R)-PK11195, a ligand that binds to activated microglia. Increased microglia activity was also prominently present in the white matter of human postmortem early-onset AD (EOAD) brain tissue. Interestingly, microglia activity in the white matter of late-onset AD (LOAD) CNS was similar to that of the aged clinically silent AD cases. These data indicate that microglia-induced neuroinflammation is predominant in the white matter of aging mice and humans as well as in EOAD brains. This white matter inflammation may contribute to the progression of neurodegeneration, and have prognostic value for detecting the onset and progression of aging and neurodegeneration.
Insights
Microglia-driven neuroinflammation predominantly affects white matter in aging and Alzheimer
Area of Science:
- Neuroscience
- Immunology
- Aging Research
Background:
- Chronic neuroinflammation, mediated by microglia, is crucial in aging and neurodegeneration.
- The spatial distribution of microglia-induced neuroinflammation (global vs. regional) remains unclear.
Purpose of the Study:
- To investigate microglia activity in different brain regions during healthy aging and Alzheimer's disease (AD).
- To determine if neuroinflammation is localized or widespread in the aging and AD brain.
Main Methods:
- Analysis of gene expression and protein markers in purified microglia from aging mouse brains.
- Quantification of microglial proteins (CD68, HLA-DR) in human postmortem white matter.
- Positron emission tomography (PET) imaging using [11C]-(R)-PK11195 in human subjects.
- Examination of human brain tissue from healthy aging, early-onset AD (EOAD), and late-onset AD (LOAD) cases.
Main Results:
- Aging mouse microglia show upregulated pro-inflammatory, phagocytic, and lipid homeostasis genes, especially in white matter.
- Human white matter exhibits age-dependent increases in microglial activation markers (CD68, HLA-DR) starting in middle age.
- PET imaging confirms increased microglia activity in aging white matter.
- Elevated microglia activity is prominent in white matter of EOAD brains and similar to aged, clinically silent AD cases in LOAD.
Conclusions:
- Microglia-induced neuroinflammation is predominantly localized in the white matter during aging and in early-onset Alzheimer's disease.
- This white matter inflammation may drive neurodegeneration and serve as a prognostic marker for aging and AD progression.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Psychoneuroimmunology: Diabetes and Cancer
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

